Virtual tumor predicts response to liver cancer immunotherapy
Researchers at Johns Hopkins have developed a computational model that simulates tumor behavior to predict patient response to liver cancer immunotherapy. This tool aims to help physicians identify the most effective treatment combinations for hepatocellular carcinoma.
Why it matters
Computational modeling could significantly improve personalized cancer treatment outcomes by reducing trial-and-error in therapy selection.
by Johns Hopkins University School of Medicine
edited by Gaby Clark , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in